MiPEP133 enhances anti-tumor immunity in nasopharyngeal carcinoma by activating CD8 + T cells.

Zhu M, Zhang H, Liang D, Huang F, Wu L, Cao Z, Chen S, Kang M

Open source

DOI
10.1186/s12967-026-08779-7
Published
2026 Aug 11
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-08779-7,
  title = {MiPEP133 enhances anti-tumor immunity in nasopharyngeal carcinoma by activating CD8 + T cells.},
  author = {Zhu M and Zhang H and Liang D and Huang F and Wu L and Cao Z and Chen S and Kang M},
  year = {2026},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-026-08779-7},
  url = {https://doi.org/10.1186/s12967-026-08779-7}
}

RIS

TY  - JOUR
TI  - MiPEP133 enhances anti-tumor immunity in nasopharyngeal carcinoma by activating CD8 + T cells.
AU  - Zhu M
AU  - Zhang H
AU  - Liang D
AU  - Huang F
AU  - Wu L
AU  - Cao Z
AU  - Chen S
AU  - Kang M
PY  - 2026
JO  - Journal of translational medicine
DO  - 10.1186/s12967-026-08779-7
UR  - https://doi.org/10.1186/s12967-026-08779-7
ER  - 

APA

M, Z., H, Z., D, L., F, H., L, W., Z, C., S, C., & M, K. (2026). MiPEP133 enhances anti-tumor immunity in nasopharyngeal carcinoma by activating CD8 + T cells.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08779-7

Source records